Loading

JSM Hepatitis

Intra-Operative Assessment of Cardiac Power Index in Liver Transplantation: The Impact on Post-Operative Myocardial Injury and Short-Term Outcomes

Research Article | Open Access | Volume 6 | Issue 1

  • 1. Department of Internal Medicine, Istanbul Medipol University, Turkey
+ Show More - Show Less
Corresponding Authors
Arzu Yazar, Department of Internal Medicine, Istanbul Medipol University, Turkey
Abstract

Background and Objectives: Despite comprehensive preoperative cardiovascular assessment, cardiovascular events remain a leading cause of postoperative mortality, due to the complexity of liver transplantation surgery. Therefore hemodynamic monitoring during liver transplantation is crucial. With PICCO (Pulse Index Continuous Cardiac Output) technology, hemodynamic parameters such as cardiac power index (CPI) can be follwed during surgery. The aim of this study is to investigate the relationship between CPI and postoperative secondary myocardial infarction.

Method: A total of 53 patients were included in the study. Patients divided into two groups according to the presence or absence of myocardial injury following liver transplantation.

Results: Postoperative myocardial injury (PMI) was observed in 28.3%(n=15) of these patients. ΔCPI was significantly lower in patients with PMI (-0.27 ± 0.11 W/m²), than those without PMI (0.08 ± 0.18 W/m²) (p<0.05). The multivariate analysis showed that the only independent predictor of PMI was ΔCPI (HR: 2.245, 95% CI: 1.145 – 4.387, p: 0.032). ROC analysis that revealed ΔCPI values lower than -0.15 W/m² were significantly associated with PMI. Peak troponin level, hospital stay and myocardial infaction prevelance were significantly higher in ΔCPI ≤ -0.15 W/m² group (all p < 0.05).

Conclusion: Our data shows that ΔCPI which constitutes the decrease in CPI during transition from the anhepatic phase to the neohepatic phase, can be used as a marker of poor cardiac prognosis in patients who underwent liver transplantation

KEYWORDS
  • Liver transplantation
  • Haemodynamic monitoring
  • Post-Reperfusion syndrome
  • Cardiovascular events
CITATION

Yazar A (2025) Intra-Operative Assessment of Cardiac Power ?ndex in Liver Transplantation: The ?mpact on Post-Operative Myocardial ?njury and Short-Term Outcomes. JSM Hepat 6(1): 1014.

INTRODUCTION

Cardiovascular events are among the leading causes of mortality in liver transplant(LT) patients [1]. Thus, screening for cardiovascular diseases play a significant role in the pretransplant evaluation. However, as it is a complex procedure and is characterized by hemodynamic instability, even patients without cardiovascular pathology are at the risk of myocardial ischemia during the procedure.

With close hemodynamic monitoring using sophisticated devices and early intervention of patients during LT, cardiovascular collapse can be prevented. Arterial pulse contour analysis and the thermo-dilution technique (PICCO) is one of these devices and it has been proven to be a reliable monitoring technique that plays a significant role in decision making [2,3], With PICCO (Pulse Index Continuous Cardiac Output) technology, many hemodynamic parameters can be followed. One of them is the cardiac power index (CPI). The ability of cardiac pumping can be represented by cardiac power output (CPO) and it is the product of mean arterial pressure (MAP) and CO. Cardiac power index (CPI) is CPO indexed to body surface area. In clinical studies it has been found to be the strongest independent predictor of hospital mortality in cardiogenic shock patients [4].

Previous studies showed that the presence of postreperfusion syndrome independently predicted postoperative myocardial injury after LT. The diagnosis of post-reperfusion syndrome is determined by examining the changes in MAP. CPI, on the other hand, provides information about cardiac contractility beyond MAP. Therefore, we considered that CPI might be a better indicator of postoperative myocardial damage. As a result, in this study, it was planned to investigate the relationship between intraoperative CPI and postoperative secondary myocardial infarction. Our hypothesis was that by retrospectively evaluating relationship between intraoperative CPI and postopreative cardiac troponin I(cTnI) levels, it may be possible to identify patients who are at the risk of postoperative myocardial injury in early stages.

METHODS

Patients who underwent coronary angiography as part of LT preoperative evaluation, from 2017 to 2021 at a single medical center and found not to have critical coronary lesion were included in this retrospective cohort study. The decision to proceed with angiography was based on a previously published protocol [5]. Patients with a history of coronary artery disease(CAD), coronary revascularisation, heart failure and significant arrythmia were excluded. Our aim was to investigate the impact of changes in CPI during the surgical procedure on myocardial perfusion, so we excluded patients already have cardiac disease or coronary artery disease, as we believed it could affect the results.

During surgery, in addition to noninvasive monitoring, patients were received invasive radial artery catheter and central venous catheter via internal juguler vein. For hemodynamic monitoring, a 5F catheter (Pulsiocath®; Pulsion Medical System, Munich, Germany) inserted through right femoral artery and connected to the PICCO2® system in all patients. The measurements were performed by transpulmonary thermodilution method by injecting 15 mL cold saline (8ºC) through the central venous line. It was indexed by each patient’s estimated body surface area.

Data collection

Hemodynamic volumetric parameters monitored by the PiCCO system were collected simultaneously at four timepoints including after anesthesia induction (T1), anhepatic phase (T2), the 30th minute of the neohepatic phase (T3) and the end of the neohepatic phase (T4) with at least three measurements made in each phase. The average of these measurements was used. Parameters monitored by the PiCCO system were cardiac index (CI), extravascular lung water index (ELWI), systemic vascular resistance index (SVRI) and stroke volume variability (SVV) values. They were recorded together with mean arterial pressure (MAP) and central venous pressure (CVP) measurements.

Baseline demographical characteristics and mortality data were obtained from medical records. Cardiac mortality was defined as death attrituable to myocardial infarction, heart failure and/or arrhythmias. Demographics, pre-existing comorbid conditions and serum troponin levels were recorded manually. MELD (Model for End-stage Liver Disease), score and RCRI (Revised Cardiac Risc ?ndex), calculation were based on patients clinical and laboratory findings.

Postoperative MI was diagnosed as a rise and/or fall of cTnI values with at least one of the following: the presence of typical angina, the presence of new ischemic findings on the ECG and detection of wall motion abnormalities on echocardiography.

Ethics

This study protocol was approved by Medipol University Faculty Hospital ethics committee. Informed consent was obtained from all patients before any study- related procedures and the study was conducted in accordance with the latest version (2013) of Declaration of Helsinki. There isn’t any ethical considerations related to the study.

Clinical outcome

The primary endpoint of the study was type 2 myocardial injury. Secondary end-points were duration of hospital stay, cardiac and all-cause mortality. The vital status of patients was ascertained by review of discharge summaries and death notes in the electronic health record.

Type 2 myocardial injury was defined as a rise and/or fall of cTn values with at least one value above the 99th percentile URL and evidence of an imbalance between myocardial oxygen supply and demand unrelated to acute coronary athero-thrombosis, requiring at least one of the following: Symptoms of acute myocardial ischaemia; New ischaemic ECG changes Development of pathological Q waves; Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a pattern consistent with an ischaemic aetiology [6]. Cardiac mortality was defined as death attributable to myocardial ischemia and infarction, heart failure or cardiac arrest because of other or unknown causes.

ΔCPI is the difference between CPI-3(neohepatic phase) and CPI-1(pre-anhepatic phase). As ΔCPI is a negative value, lower ΔCPI indicates a large gap between CPI-3 and CPI-1.

STATISTICAL ANALYSIS

Statistical analyses were conducted with the use of SPSS (version 17.0; SPSS, Chicago, Illinois). Data were expressed as percentage for categorical variables and as mean ± SD for continuous variables. Shapiro-Wilk test was conducted to test for normal distribution. Comparisons among continuous variables were performed by using the Student t test and Mann-Whitney U test for independent samples that show normal and non-normal distribution respectively. Associations of the categorical variables between groups were determined with the use of chi- square test. Statistical significance was defined as a p value< 0.05 for all comparisons. Pearson correlation analysis was used to test the relationship between the change in cardiac power index (ΔCPI) and the peak post-operative Troponin level, as well as the duration of hospital stay (days). The results of the correlations were shown on separate scatter-dot graphs with the corresponding r and p values. The predictors of post-operative myocardial injury were tested by univariate and multivariate logistic regression analyses. In univariate logistic regression analyses age, ΔCPI, operation time (OT), and vasopressor need (VN), found to be associated with myocardial injury following liver transplantation. These variables were tested in the multivariate analysis. Results were expressed as the p value and hazard ratio (HR), in CI of 95%. A receiver operating characteristic (ROC) curve was generated for discriminative ability of ΔCPI to predict myocardial injury after LT. Results were expressed as area under the curve (AUC), standard deviation (SD), p value, and 95% confidence intervals (CI). We divided patients into 2 groups based on the ΔCPI value derived from the ROC analysis. Post-operative outcome variables were compared according to the cut-off ΔCPI value. The results were expressed in a separate table.

RESULTS

A total of 53 patients were included in the study and postoperative secondary myocardial injury (PMI) was observed in 28.3% (n=15) of these patients. Basal characteristics of patients with and without PMI are summarized in Table. There was no significant difference between the two groups in terms of gender, etiology of liver failure, revised cardiac index and MELD scores, EF, sPAP, BSA, smoking status and the presence of comorbid diseases (diabetes mellitus, hypertension, arrhythmia, heart failure, cerebrovascular disease, renal disease, peripheral artery disease) (p>0.05 for all). The mean age of patients with PMI is significantly higher (61.2 ± 8.6 years) than for those without PMI (55.8 ± 7.1 years) (p<0.05). Also, there is a significant difference between the two groups in terms of postoperative NT-proBNP levels (832 ± 1751.1 pg/mL and 390 ± 514.5 pg/mL, respectively) (p<0.05).

Intra-operatively assessed hemodynamic parameters and surgical features of the liver transplant patients compared based on the occurrence of myocardial injury following surgery is shown in Table. ΔCPI was significantly lower in patients with PMI (-0.27 ± 0.11 W/m²) than those without PMI (0.08 ± 0.18 W/m²) (p<0.05). Also, intraoperative vasopressor need was significantly higher in patients with PMI (87% vs 24%, p<0.05). Furthermore, operation time was considerably longer in patients with PMI than those without PMI (505 ± 21 minutes vs 408 ± 31 minutes, p<0.05).

The mean ΔCPI was significantly lower in patients with PMI than those without PMI as shown on Figure. Also, Figure shows that there was a negative correlation between ΔCPI and peak Troponin levels (r=-0,645, p<0,001). Similarly, a negative correlation was present between ΔCPI and the duration of hospital stay (Figure) (r=-0,587 p=<0,001).

We performed univariate and multivariate logistic regression analyses to determine the independent predictors of PMI. Significant variables in the univariate model were found as ΔCPI (HR: 2.326, 95% CI: 1.511 – 3.716, p: 0,012) and operation time (HR: 2.651, 95% CI:1.104 – 6.317, p< 0.001). The multivariate analysis showed that the only independent predictor of PMI was ΔCPI (HR: 2.245, 95% CI: 1.145 – 4.387, p: 0.032) following liver transplantation. In order to establish a cut-off value for ΔCPI to determine post-operative myocardial injury, we performed ROC analysis that revealed ΔCPI values lower than -0.15 W/m² were significantly associated with PMI. According to the cut-off ΔCPI value, we devided patients into 2 groups as 1) ΔCPI ≤ -0.15 W/m² and 2) ΔCPI > -0.15 W/m². Table shows the comparison of the post-operative outcome variables between the groups defined according to the cut-off value for ΔCPI assessed during the surgical procedure. Peak troponin level, hospital stay and myocardial infarction prevalence were significantly higher in ΔCPI ≤ -0.15 W/m² group (all p < 0.05). Figure shows the graphical demonstration of the association of low ΔCPI (≤ -0.15 W/ m²) with cardiac and all-cause mortality, respectively.

DISCUSSION

In this study, the relationship between intra-operatively measured CPI and postoperative myocardial injury in liver transplantation patients was investigated. The main findings of the study can be listed as follows; there is a negative correlation between ΔCPI and postoperative secondary myocardial injury. Also hospital stay, cardiac and all-cause mortality is higher in patients with lower ΔCPI. Furthermore, it has been demonstrated that this relationship is independent of other factors.

With investment and updates in surgical techniques and anesthetic management, mortality rates after LT have been significantly improved. However, as it is considered a complex procedure and is characterized by hemodynamic instability, significant instability challenges remain for LT. Especially transition from the anhepatic phase to neohepatic phase is the most critical time of the surgery. Abrupt hemodynamic and metabolic changes during that time may cause cardiovascular collapse, which is associated with adverse outcomes during the postoperative period [7].

To prevent cardiovascular collapse, close hemodynamic monitoring and early intervention of patients during LT are critical. Hence, sophisticated invasive monitoring with devices which offer crucial information for the successful management of patients is required during the surgery. Arterial pulse contour analysis and thermo- dilution technique (PICCO) is one of these devices and it has been proven to be a reliable monitoring technique which plays a significant role in making decisions [2]. With PICCO technology, many hemodynamic parameters can be followed. One of them is the cardiac power index (CPI). CPI represents the power of left ventricular cardiac output in Watt. It is the product of pressure (MAP) and flow (CO) [8]. In several studies it was shown that, CPI is associated with prognosis of heart failure patients [9-11]. Also, it has been found to be the strongest independent predictor of hospital mortality in cardiogenic shock patients [4].

In our study we planned to investigate the relationship between intraoperative CPI and postoperative secondary myocardial injury. For this reason, the relationship between CPI measured during the three phases (pre- anhepatic, anhepatic and neo-hepatic phase), of surgery and the presence of postoperative myocardial injury in patients who are evaluated with coronary angiography before LT and found not to have critical coronary lesion was investigated. Unlike other studies which indicate that, CPI is a predictor of worse prognosis after surgery, in our study there was no correlation between CPI measured during all phases of the surgery and PMI. The phase at which reperfusion syndrome occurs is when the transition from the anhepatic phase to the neohepatic phase takes place. We also raised the question of whether the change in CPI during this phase could be related to postoperative myocardial perfusion. At this point, we decided to investigate the relationship between postoperative MI and ΔCPI, which is the difference between CPI-3(neohepatic phase) and CPI-1(pre-anhepatic phase). It was found out that there is a negative correlation between postoperative secondary myocardial injury and ΔCPI. This finding supported our idea that, patients who experienced significant decrease in CPI during transition from the anhepatic phase to the neohepatic phase, which constitutes the reperfusion phase, were more prone to postoperative myocardial injury. That result is compatible with other studies which show that post-reperfusion syndrome (PRS), which means 30% decrease in the mean arterial pressure(MAP) for at least a minute and which appears in the first five minutes after graft reperfusion at neohepatic phase [12], is associated with adverse cardiovascular events [13]. As far as we know, this is the first study related to ΔCPI, which is not routinely used as a marker during surgeries.

In our study, none of patients experienced PRS. Although the relationship between MAP and poor outcomes was demonstrated previously by several studies [14,15] in our study there was not any correlation between MAP changes during phases of the surgery and PMI. However patients with lower ΔCPI, even did not experienced PRS, are more prone to PMI. Also their hospital stay was longer and their all-cause mortality and cardiac mortality rate were higher. As a result it can be suggested that ΔCPI is a more sensitive cardiovascular prognostic marker than MAP in liver transplantation patients.

Taking these findings into consideration, it can be stated that in patients undergoing liver transplantation, irrespective of the risks in preoperative assessment, postoperative adverse cardiac events could be reduced with effective intraoperative hemodynamic management. The significance of hemodynamic monitoring during liver transplantation has already been demonstrated through previous studies [16,17]. During the surgery hemodynamic status of the LT recipient can be monitored using MAP, CVP [18]. However it was shown that they are poor predictors of ventricular filling volume and fluid responsiveness during various conditions [19], PiCCO systems, altough have not been universally validated for LT surgery, promise hope for the future. We attributed this situation to the fact that they also provided information about cardiac output, which could indicate a better reflection of the cardiac condition, apart from blood pressure. However, in our study, we found an association with ΔCPI rather than CPI itself in relation to myocardial ischemia. Although we hypothesized that this could be a result of the significant decrease in cardiac output during the transition to the neohepatic phase, reaching a definitive conclusion is not possible due to the limited number of patients. We believe that this question may be answered in the future through more comprehensive studies.

CONCLUSION

ΔCPI which constitutes the decrease in CPI during transition from the anhepatic phase to the neohepatic phase, can be used as a marker of poor cardiac prognosis in patients who underwent liver transplantation. However, due to the limitation in the number of patients in our study, we can not fully explain the mechanism and can not provide practical clinical applications for this finding, Close follow-up of the patients with lower ΔCPI may provide a significant benefit to reduce cardiovascular events by ensuring early diagnosis and treatment.

LIMITATIONS

The major limitation of our study was the small sample size, so the results should be validated in a larger population. Another drawback of the study was that although the post-surgery need for vasopressor therapy was investigated, a standardized vasopressor treatment during the surgical procedure was lacking, thus preventing a meaningful comparison. As a result, the impact of treatments administered during surgery on surgical outcomes remains unknown.

DATA STATEMENT

Due to the sensitive nature of the questions asked in this study, survey respondents were assured raw data would remain confidential and would not be shared.

Data not available / The data that has been used is confidential 

AUTHOR CONTRIBUTION

A.Yazar, I.O?uz Karaca, Tumay Yanaral had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

A. Yazar should be regarded as first author.

Drafting of the manuscript and ritical revision of the manuscript for important

intellectual content: A.Yazar, I.O?uz Karaca, Tumay Yanaral

Statistical analysis: I.O?uz Karaca

Supervision: A.Yazar, I.O?uz Karaca, Tumay Yanaral, Gökhan Ertu?rul, Y. Ziya ?ener

REFERENCES
  1. 1.Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplantation. 2010; 10: 1420-1427.
  2. Wesseling K. A simple device for the continuous measurement of cardiac output. Its model basis and experimental varification. Adv Cardiovasc Phys. 1983; 5: 16-52.
  3. Della Rocca G, Costa MG, Coccia C, Pompei L, Di Marco P, Vilardi V, et al. Cardiac output monitoring: aortic transpulmonary thermodilution and pulse contour analysis agree with standard thermodilution methods in patients undergoing lung transplantation. Canad J Anaes. 2003; 50: 707-711.
  4. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am College Cardiol. 2004; 44: 340-348.
  5. Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2012; 126: 617-663.
  6. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018; 72: 2231-2264.
  7. Reich DL, Wood Jr RK, Emre S, Bodian CA, Hossain S, Krol M, et al. Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothoracic Vasc Anesthesia. 2003; 17: 699-702.
  8. Tan L. Clinical and research implications of new concepts in the assessment of cardiac pumping performance in heart failure. Cardiovas Res. 1987; 21: 615-22.
  9. Cotter G, Moshkovitz Y, Kaluski E, Milo O, Nobikov Y, Schneeweiss A, et al. The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Failure. 2003; 5: 443-451.
  10. Williams S, Cooke G, Wright D, Parsons W, Riley R, Marshall P, et al. Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J. 2001; 22: 1496-1503.
  11. Cotter G, Moshkovitz Y, Milovanov O, Salah A, Blatt A, Krakover R, et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Failure. 2002; 4: 227-234.
  12. Aggarwal S. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc. 1987; 19: 54-55.
  13. Bukowicka B, Abi Akar R, Olszewska A, Smoter P, Krawczyk M. The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. Ann Transplant. 2011; 16: 26-30.
  14. Aggarwal S, Kang Y, Freeman J, Fortunato F, Pinsky MR, editors. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplantation proceedings. 1987: Elsevier USA.
  15. Paugam-Burtz C, Kavafyan J, Merckx P, Dahmani S, Sommacale D, Ramsay M, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transplant. 2009; 15: 522-529.
  16. Rudnick MR, De Marchi L, Plotkin JS. Hemodynamic monitoring during liver transplantation: A state of the art review. World J Hepatol. 2015; 7: 1302.
  17. Costa M, Chiarandini P, Della Rocca G, editors. Hemodynamics during liver transplantation. Transplant Procee. 2007:
  18. Jeong SM. Postreperfusion syndrome during liver transplantation. Korean J Anesthesiol. 2015; 68: 527-539.
  19. Bendjelid K, Rom JA. Fluid responsiveness in mechanically ventilated patients: a review of indices used in intensive care. Appl Physiol Intensive Care Med. 2009: 133-141.

Yazar A (2025) Intra-Operative Assessment of Cardiac Power ?ndex in Liver Transplantation: The ?mpact on Post-Operative Myocardial ?njury and Short-Term Outcomes. JSM Hepat 6(1): 1014.

Received : 05 Mar 2025
Accepted : 22 Apr 2025
Published : 23 Apr 2025
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X